InvestorLens

IMVT — IMMUNOVANT INC

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying IMVT?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Net accumulation · 1 buying vs 0 selling last quarter
66
Macro Tailwind
Macro conditions are mixed for this sector
57
Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their IMVT position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).

Supporting evidence
  • +1 tracked investor added or increased positions last quarter (Paul Tudor Jones)
  • +4 tracked investors reported holding IMVT at their latest filing
  • +Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.

About IMMUNOVANT INC (IMVT)

IMMUNOVANT INC (IMVT) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Andreas Halvorsen (Viking Global Investors), valued at $66M. Across recent filings, tracked investors recorded 5 new positions, 2 increased, 2 reduced, and 3 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in IMVT

58
/100
Mixed Activity
Added / Increased7
Reduced2
Exited3
BearishBullish
Crowded Trade Score™

How many top investors track IMVT

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

IMVT Ownership Composition

How IMMUNOVANT INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
80% of tracked value
Institutions
4
tracked investors
Total Reported
$29.5M
combined 13F value
Types3
  • Multi-Strategy / Quant80.3%
  • Value & Distressed12.2%
  • Macro7.5%
Multi-Strategy / Quant(2)
80.3%
Value & Distressed(1)
12.2%
Macro(1)
7.5%

Tracked investors currently reporting IMVT

2 tracked investors have since exited this position — listed separately below.

  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    328.7K
    Value
    $12.7M
    % Portfolio
    0.00%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    285.3K
    Value
    $11M
    % Portfolio
    0.00%
  • David EinhornJun 30, 2026
    DME Capital Management, LP
    Shares
    93.5K
    Value
    $3.6M
    % Portfolio
    0.09%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    57.1K
    Value
    $2.2M
    % Portfolio
    0.00%

Previously held IMVT

These investors reported IMVT in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Andreas HalvorsenViking Global Investors1.1M$19.1MMar 31, 2025
Steve CohenPoint72 Asset Management2M$50.8MDec 31, 2025

Recent activity

Frequently asked questions

How many institutional investors hold IMVT?
4 tracked institutional investors disclosed a position in IMVT (IMMUNOVANT INC) in their most recent 13F filing.
Who is the largest institutional holder of IMVT?
Andreas Halvorsen, Viking Global Investors, holds the largest disclosed position in IMVT, valued at $66M.
Did institutional ownership of IMVT increase or decrease?
Across recent 13F filings, tracked investors recorded 5 new positions, 2 increased, 2 reduced, and 3 fully exited IMVT.
Where does this IMVT ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.